Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02331784 · ClinicalTrials.gov registry record · NA
Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease
A NA study, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT02331784: Completed NA study, sponsored by Posit Science Corporation.
NCT02331784 is a NA study that has completed, run by Posit Science Corporation. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02331784, a NA study, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the effects of the experimental treatment (cognitive training) further outlined in this protocol on the cognitive abilities (e.g., processing speed, attention, working memory, and executive function), brain functionality, functional status and quality of life of individuals with age-related cognitive decline as compared to a computer-based active control.
Primary Outcome
Change in performance on global cognitive composite score based on the average of all normalized assessment measures.
Interventions
- BEHAVIORAL Computerized Plasticity-based Software
- BEHAVIORAL Commercially available Video Game
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-04-20 |
| Phase | NA |
What the finished NCT02331784 record still lists
NCT02331784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Computerized Plasticity-based Software is the first listed.
NCT02331784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02331784 about?
NCT02331784 is a clinical study titled "Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease". The primary objective of this study is to evaluate the effects of the experimental treatment (cognitive training) further outlined in this protocol on the cognitive abilities (e.g., processing speed, attention, working memory, and executive function), brain functionality, functional status and quali...
What is the current status of trial NCT02331784?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2015-04. Estimated completion is 2017-04-20.
What interventions are being tested in trial NCT02331784?
The interventions under investigation include: Computerized Plasticity-based Software (BEHAVIORAL), Commercially available Video Game (BEHAVIORAL).
Who is sponsoring clinical trial NCT02331784?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02331784's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia